Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the market and more in the works.| Forbes
Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 million at a $3.5 billion valuation.| Forbes
Millions of people get cataract surgery every year. Startup ForSight, backed with $125 million in fresh funding, is betting a robot can do it better than humans.| Forbes
The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.| Forbes
Investors are always encouraging startups to push the innovation envelope. General Catalyst’s Hemant Taneja is applying that advice to his own firm.| Forbes